跳至主要内容
临床试验/JPRN-jRCT2080222488
JPRN-jRCT2080222488未知3 期

Phase 3 Clinical Study of CN-801 - Double-blind comparative study in patients with excessive daytime sleepiness associated with idiopathic hypersomnia

Alfresa Pharma Corporation0 个研究点开始时间: 2014年5月22日最近更新:
适应症

试验速览

阶段
3 期

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 16age old 至 <= 64age old(—)
性别
All

入选标准

  • Diagnosis of idiopathic hypersomnia based on the International Classification of Sleep Disorders, second edition (ICSD-2)

排除标准

  • Patients with narcolepsy, restless legs syndrome, periodic limb movement disorder, or sleep apnea syndrome
  • Patients working irregular shifts or night shifts
  • Patients with chronic sleep deprivation or patients with extremely irregular bed times

研究者

相似试验